[Vasodilating action of (+/-)-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline (TMI) derivatives (author's transl)].
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000818:Animals; D001783:Blood Flow Velocity; D002339:Carotid Arteries / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents
D007546:Isoquinolines; D014665:Vasodilator Agents; D012110:Reserpine; D011433:Propranolol; D015105:3',5'-Cyclic-AMP Phosphodiesterases